Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.
about
Alteration of energy substrates and ROS production in diabetic cardiomyopathyHIV-1 Vpr enhances PPARβ/δ-mediated transcription, increases PDK4 expression, and reduces PDC activityModulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferatorsAdaptation of peroxisome proliferator-activated receptor alpha to hibernation in batsPPARα modulates the TSH β-subunit mRNA expression in thyrotrope TαT1 cells and in a mouse model.Whole genome association study identifies regions of the bovine genome and biological pathways involved in carcass trait performance in Holstein-Friesian cattleActivation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes.Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growthPeroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.Peroxisome proliferator-activated receptors alpha, Beta, and gamma mRNA and protein expression in human fetal tissues.The Role of PPARα Activation in Liver and Muscle.Regulation of retinoid-mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin.Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism.A role for peroxisome proliferator-activated receptors in the immunopathology of schistosomiasis?Peripheral blood gene expression profiling in Sjögren's syndromeHuman constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1).PPARγ stimulates expression of L-type amino acid and taurine transporters in human placentas: the evidence of PPARγ regulating fetal growth.The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone.Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptorsPeroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.Rapid pain modulation with nuclear receptor ligands.Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdeltaReal-time recording of circadian liver gene expression in freely moving mice reveals the phase-setting behavior of hepatocyte clocks.Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.PPARgamma Inhibitors as Novel Tubulin-Targeting Agents.NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?Genome-wide transcriptome expression in the liver of a mouse model of high carbohydrate diet-induced liver steatosis and its significance for the diseasePPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.Influence of conjugated linoleic acids on functional properties of vascular cells.Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections.PPAR gamma, bioactive lipids, and cancer progression.Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.Catalpol reduces the production of inflammatory mediators via PPAR-γ activation in human intestinal Caco-2 cells.
P2860
Q27014882-E48C0278-11EF-4D9C-8CE3-24DD84AA7E0DQ28294338-871E625A-F1CA-4E4F-BF55-ADB85526BE64Q28564380-715EFB88-8E06-48F2-A145-ACE8062AD315Q28647311-2FA0E461-6826-4536-81E0-4B45C02D202AQ30317924-D4427915-66EE-44F9-AA40-330B7858189EQ30591155-C0D3F8B1-0681-456A-B31A-2869DD1EB62EQ33618276-65924AF8-85EF-4ADB-8EB4-A6A59E15CEB4Q33695158-E4D29DBE-3C25-4C2A-829E-05BD1504CEC6Q33770896-C9F368FD-F0F4-4D78-BF08-E51FCCFB988EQ33993702-B784606F-0C7E-450E-BD3B-8A59F3E3E18EQ34035410-926ED8EB-B5E6-4657-8EEE-B83BB60960FEQ34106233-344F22BE-9FDA-4388-9082-F768BC92A4F3Q34701888-B49DBB58-C325-449F-B99D-8650D159998DQ34741796-958FFFB3-BF89-44B7-809C-B65BFB41551FQ35063224-EBDF34CE-68FC-4DB1-BDDD-93FE26644EBAQ35101448-AD7BFD23-B302-4FD5-B19C-152FB995BE64Q35101462-AC641EDB-AA40-4A38-B9A4-92F23FF976C9Q35740973-1A32E34E-FA69-4400-981E-C8788328069FQ35891555-51EA4839-4761-45BE-AE18-85D75D7B0FD5Q35905696-9FEAD3C8-473C-48D7-B864-7B536C8EB2F9Q35925357-6200519B-DD8B-495A-A2F4-F16FC879F57DQ36465015-AC0AF6C0-141E-45C3-8ADA-1C2D3BDEF801Q36591722-F35C3FF9-81E0-4C68-87E7-6BBB096BDE4EQ36733873-EF3A24A2-3B9A-4907-B2D6-434FDC35D85DQ36943828-46CB28E7-4CA2-49B1-BFA5-33E578B859E7Q36964412-2D372960-7662-40DB-9B3B-D4BE2616DE19Q36995029-575281CB-AC72-4E04-8B90-87D2051D5EE6Q37019229-5644B3D3-46CF-495A-B4C3-B1D0B1B19078Q37088341-5B8FF237-6C27-4EE3-8127-FE077C6E4E59Q37101754-CFB4C295-C55F-46D0-89B9-7A08CD6E6CF9Q37176066-2D7F5758-5D18-4238-8AC3-CEDC627A7696Q37182798-7FBD611B-9C51-4F6C-A316-9C208A291D24Q37278180-310BCCDB-AC63-4F4A-8E1C-CB6E041E0FE9Q37362740-E68CE2B3-7FF0-4B3D-A06A-9B68A078B22BQ37557746-7EFBC8A8-1DC2-4B63-A5A4-D82DEEE06558Q37695084-47D16643-8A70-4B76-AFB2-2E9305F9ABE8Q37971590-073DDDA5-50AB-4EED-A735-2931E7FBFE2EQ38246264-3ED80154-F088-4843-8F4C-6F44EB1A09C3Q38782659-62C4E5CE-7704-41C0-A667-B951567377E8Q38783875-21712406-1250-4970-8829-F5B3B619B846
P2860
Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Multiple expression control me ...... eptors and their target genes.
@ast
Multiple expression control me ...... eptors and their target genes.
@en
type
label
Multiple expression control me ...... eptors and their target genes.
@ast
Multiple expression control me ...... eptors and their target genes.
@en
prefLabel
Multiple expression control me ...... eptors and their target genes.
@ast
Multiple expression control me ...... eptors and their target genes.
@en
P2093
P1476
Multiple expression control me ...... eptors and their target genes.
@en
P2093
Liliane Michalik
Nguan Soon Tan
Walter Wahli
P304
P356
10.1016/J.JSBMB.2004.12.025
P577
2005-02-01T00:00:00Z